Patent · US Expired

Serine protease inhibitor nucleic acid molecules and uses thereof

US6479253B1 · kind B1 · utility

6Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 1998
Grant dateNov 12, 2002
Priority date
Expiry dateJan 9, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to flea serine protease inhibitor proteins; to flea serine protease inhibitor nucleic acid molecules, including those that encode such serine protease inhibitor proteins; to antibodies raised against such serine protease inhibitor proteins; and to compounds that inhibit flea serine protease inhibitor activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from hematophagous ectoparasite infestation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.